{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:53:19Z","timestamp":1774954399075,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes & Metabolism"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.diabet.2007.06.001","type":"journal-article","created":{"date-parts":[[2007,8,18]],"date-time":"2007-08-18T11:16:56Z","timestamp":1187435816000},"page":"303-309","source":"Crossref","is-referenced-by-count":21,"title":["Microalbuminuria and\u00a0urinary albumin excretion: French clinical practice guidelines"],"prefix":"10.1016","volume":"33","author":[{"given":"J.-M.","family":"Halimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hadjadj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Aboyans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.-A.","family":"Allaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-Y.","family":"Artigou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Beaufils","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Berrut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-P.","family":"Fauvel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Gin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nitenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-C.","family":"Renversez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Rusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Valensi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cordonnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.diabet.2007.06.001_bib1","first-page":"S79","article-title":"Diabetic nephropathy","volume":"27","year":"2004","journal-title":"Diab. Care"},{"key":"10.1016\/j.diabet.2007.06.001_bib2","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.diabet.2007.06.001_bib3","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00004872-200306000-00001","article-title":"2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension","volume":"21","year":"2003","journal-title":"J. Hypertens."},{"key":"10.1016\/j.diabet.2007.06.001_bib4","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"42","author":"Sarnak","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.diabet.2007.06.001_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s001250050895","article-title":"Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure","volume":"41","author":"Fioretto","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2007.06.001_bib6","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.2337\/diacare.26.8.2389","article-title":"Microalbuminuria and mortality in long-duration type 1 diabetes","volume":"26","author":"Allen","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2007.06.001_bib7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.diabet.2007.06.001_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM198407123110204","article-title":"Predicting diabetic nephropathy in insulin-dependent patients","volume":"311","author":"Mogensen","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diabet.2007.06.001_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0272-6386(12)70184-1","article-title":"Monitoring diabetic nephropathy: glomerular filtration rate and abnormal albuminuria in diabetic renal disease-reproducibility, progression, and efficacy of antihypertensive intervention","volume":"22","author":"Mogensen","year":"1993","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.diabet.2007.06.001_bib10","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1681\/ASN.2006080872","article-title":"Microalbuminuria and the risk of progressive renal function decline in type 1 diabetes","volume":"18","author":"Perkins","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.diabet.2007.06.001_bib11","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/bmj.313.7060.779","article-title":"Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study","volume":"313","author":"Rossing","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.diabet.2007.06.001_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/ki.1982.89","article-title":"Graded exercise and protein excretion in diabetic man and the effect of insulin treatment","volume":"21","author":"Vittinghus","year":"1982","journal-title":"Kidney Int."},{"key":"10.1016\/j.diabet.2007.06.001_bib13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00004872-199304000-00019","article-title":"Microalbuminuria in treated hypertensive men at high risk of coronary disease. The Risk Factor Intervention Study Group","volume":"11","author":"Agewall","year":"1993","journal-title":"J. Hypertens."},{"key":"10.1016\/j.diabet.2007.06.001_bib14","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.2337\/db06-1646","article-title":"Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes mellitus","volume":"56","author":"Araki","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2007.06.001_bib15","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1161\/01.CIR.0000146378.65439.7A","article-title":"Prevention of Renal and Vascular Endstage Disease Intervention Trial. (PREVEND IT) Investigators. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria","volume":"110","author":"Asselbergs","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.diabet.2007.06.001_bib16","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/00004872-199816090-00014","article-title":"Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension","volume":"6","author":"Bigazzi","year":"1998","journal-title":"J. Hypertens."},{"key":"10.1016\/j.diabet.2007.06.001_bib17","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1161\/01.ATV.19.8.1992","article-title":"Urinary albumin excretion: an independent predictor of ischemic heart disease","volume":"19","author":"Borch-Johnsen","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.diabet.2007.06.001_bib18","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.2337\/diacare.28.10.2525","article-title":"Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes","volume":"28","author":"Branstma","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2007.06.001_bib19","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/CIRCULATIONAHA.106.177321","volume":"114","author":"Brosius","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.diabet.2007.06.001_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/bmj.300.6720.297","article-title":"Microalbuminuria as predictor of increased mortality in elderly people","volume":"300","author":"Damsgaard","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.diabet.2007.06.001_bib21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1681\/ASN.2006040394","article-title":"Central obesity, incident microalbuminuria and change in creatinine clearance in the epidemiology of diabetes interventions and complications study","volume":"18","author":"de Boer","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.diabet.2007.06.001_bib22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1365-2796.2001.00833.x","article-title":"Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity","volume":"249","author":"Hillege","year":"2001","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.diabet.2007.06.001_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1523-1755.2001.00793.x","article-title":"The natural history of renal disease in Australian Aborigines. Part 2. Albuminuria predicts natural death and renal failure","volume":"60","author":"Hoy","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.diabet.2007.06.001_bib24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.HYP.0000154082.72286.2a","article-title":"Reduction in albuminuria to reduction in cardiovascular events in hypertensive patients: Losartan intervention fot endpoint reduction in hypertension study","volume":"45","author":"Ibsen","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.diabet.2007.06.001_bib25","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1097\/00004872-200409000-00026","article-title":"Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy","volume":"22","author":"Ibsen","year":"2004","journal-title":"J. Hypertens."},{"key":"10.1016\/j.diabet.2007.06.001_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2796.2006.01679.x","article-title":"Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular disease","volume":"260","author":"Klausen","year":"2006","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.diabet.2007.06.001_bib27","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1111\/j.1523-1755.2004.09215.x","article-title":"Albuminuria as a predictor of cardiovascular and renal outcomes in people with known artherosclerotic cardiovascular disease","volume":"92","author":"Mann","year":"2004","journal-title":"Kidney Int suppl"},{"key":"10.1016\/j.diabet.2007.06.001_bib28","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/00004872-199816090-00014","article-title":"Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension","volume":"16","author":"Bigazzi","year":"1998","journal-title":"J. Hypertens."},{"issue":"92","key":"10.1016\/j.diabet.2007.06.001_bib29","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1111\/j.1523-1755.2004.09205.x","article-title":"An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population","author":"Verhave","year":"2004","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.diabet.2007.06.001_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jns.2007.01.066","article-title":"Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects","volume":"255","author":"Wada","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.diabet.2007.06.001_bib31","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0140-6736(88)92657-8","article-title":"Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey","volume":"2","author":"Yudkin","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2007.06.001_bib32","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1161\/01.CIR.0000158434.69180.2D","article-title":"Low-grade albuminuria and the risks of hypertension and blood pressure progression","volume":"111","author":"Wang","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.diabet.2007.06.001_bib33","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.2337\/diacare.28.10.2525","article-title":"Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes","volume":"28","author":"Branstma","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2007.06.001_bib34","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/ije\/dyl115","article-title":"Albuminuria as a marker of the risk of developing type 2 diabetes in non-diabetic Aboriginal Australians","volume":"35","author":"Wang","year":"2006","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.diabet.2007.06.001_bib35","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1600-6143.2007.01665.x","article-title":"Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients","volume":"7","author":"Halimi","year":"2007","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.diabet.2007.06.001_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0959-8049(97)10003-X","article-title":"Microalbuminuria in patients with lung cancer","volume":"34","author":"Pedersen","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.diabet.2007.06.001_bib37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","article-title":"Intensified multifactorial intervention in patients with type 2 diabets mellitus and microalbuminuria: the steno type 2 randomized study","volume":"353","author":"Gaede","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2007.06.001_bib38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/bmj.37970.629537.0D","article-title":"Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)","volume":"328","author":"Marre","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.diabet.2007.06.001_bib39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 Diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diabet.2007.06.001_bib40","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa042167","article-title":"Preventing microalbuminuria in type 2 diabetes","volume":"351","author":"Ruggenenti","year":"2004","journal-title":"N. Engl. J. Med."}],"container-title":["Diabetes & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363607001437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363607001437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T07:42:04Z","timestamp":1556782924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363607001437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1262363607001437"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2007.06.001","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}